Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjögren's Syndrome by Nocturne, G., Virone, A., Ng, Wan‐Fai, Le Guern, V., Hachulla, E., Cornec, D., Daien, C., Vittecoq, O., Bienvenu, B., Marcelli, C., Wendling, D., Amoura, Z., Dhote, R., Lavigne, C., Fior, R., Gottenberg, J. E., Seror, R., Mariette, X.

Get full text

Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome by Marie, I, Josse, S, Decaux, O, Dominique, S, Diot, E, Landron, C, Roblot, P, Jouneau, S, Hatron, P.Y, Tiev, K.P, Vittecoq, O, Noel, D, Mouthon, L, Menard, J.-F, Jouen, F

Get full text

Usefulness of monitoring of B cell depletion in rituximab‐treated rheumatoid arthritis patients in order to predict clinical relapse: a prospective observational study by Trouvin, A.‐P., Jacquot, S., Grigioni, S., Curis, E., Dedreux, I., Roucheux, A., Boulard, H., Vittecoq, O., Le Loët, X., Boyer, O., Goëb, V.

Get full text

Interstitial Lung Disease in Anti–Jo‐1 Patients With Antisynthetase Syndrome by Marie, I., Josse, S., Hatron, P. Y., Dominique, S., Hachulla, E., Janvresse, A., Cherin, P., Mouthon, L., Vittecoq, O., Menard, J.‐F., Jouen, F.

Get full text

Crizotinib-induced osteitis mimicking bone metastasis in a stage IV ALK-rearranged NSCLC patient: a case report by Guisier, F, Piton, N, Bellefleur, M, Delberghe, N, Avenel, G, Angot, E, Vittecoq, O, Ould-Slimane, M, Morisse-Pradier, H, Salaun, M, Thiberville, L

Get full text

Pre-silencing of genes involved in the electron transport chain (ETC) pathway is associated with responsiveness to abatacept in rheumatoid arthritis by Derambure, C, Dzangue-Tchoupou, G, Berard, C, Vergne, N, Hiron, M, D'Agostino, M A, Musette, P, Vittecoq, O, Lequerré, T

Get full text

European League Against Rheumatism Sjögren's Syndrome Disease Activity Index and European League Against Rheumatism Sjögren's Syndrome Patient‐Reported Index: A Complete Picture of... by Seror, R., Gottenberg, J. E., Devauchelle‐Pensec, V., Dubost, J. J., Le Guern, V., Hayem, G., Fauchais, A.‐L., Goeb, V., Hachulla, E., Hatron, P. Y., Larroche, C., Morel, J., Pedriger, A., Puechal, X., Rist, S., Saraux, A., Sene, D., Sibilia, J., Vittecoq, O., Zarnitsky, C., Labetoulle, M., Ravaud, P., Mariette, X.

Get full text

The impact of an in-department pharmacist on the prevention of drug iatrogenesis in a rheumatology department by Soubieux, A., Chenailler, C., Lattard, C., Banse, C., Kozyreff-Meurice, M., Gondé, H., Lequerré, T., Vittecoq, O., Varin, R.

Get full text

Clinical manifestations and outcome of anti-PL7 positive patients with antisynthetase syndrome by Marie, I, Josse, S, Decaux, O, Diot, E, Landron, C, Roblot, P, Jouneau, S, Hatron, P.Y, Hachulla, E, Vittecoq, O, Menard, J.-F, Jouen, F, Dominique, S

Get full text

Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome by Goëb, V, Salle, V, Duhaut, P, Jouen, F, Smail, A, Ducroix, J.-P, Tron, F, Le Loët, X, Vittecoq, O

Get full text

Anti-TNF-alpha-induced systemic lupus syndrome by Debandt, M, Vittecoq, O, Descamps, V, Le Loët, X, Meyer, O

Get full text

Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three‐year prospective study in community‐recruited patients by Vittecoq, O., Pouplin, S., Krzanowska, K., Jouen‐Beades, F., Ménard, J. F., Gayet, A., Daragon, A., Tron, F., Le Loët, X.

Get full text

Long term outcome of patients with low level of cryoglobulin (< 0.05 g/L) by Eble, V, Legallicier, B, Joly, P, Vittecoq, O, Caron, F, Tamion, F, Ducrotte, P, Levesque, H, Menard, J.-F, Jouen, F, Guerrot, D, Marie, I

Get full text

Gene profiling predicts rheumatoid arthritis responsiveness to IL-1Ra (anakinra) by BANSARD, Carine, LEQUERRE, Thierry, LE LOËT, Xavier, SALIER, Jean-Philippe, DERAMBURE, Céline, VITTECOQ, Olivier, HIRON, Martine, DARAGON, Alain, POUPLIN, Sophie, DAVEAU, Maryvonne, BOYER, Olivier, TRON, François

Get full text

Anti-annexin II Antibodies in Systemic Autoimmune Diseases and Antiphospholipid Syndrome by Salle, V., Mazière, J. C., Smail, A., Cévallos, R., Mazière, C., Fuentes, V., Tramier, B., Makdassi, R., Choukroun, G., Vittecoq, O., Goëb, V., Ducroix, J. P.

Get full text

Therapeutic update in rheumatoid arthritis by Lequerré, T, Avenel, G, Vittecoq, O

Get full text

Psoriatic arthritis during rituximab treatment of granulomatosis with polyangiitis: a new paradoxical side effect? by Aussy, A, Girszyn, N, Vandhuick, T, Marie, I, Vittecoq, O, Lévesque, H, Benhamou, Y

Get full text

Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnos... by Goëb, V., Dieudé, P., Daveau, R., Thomas-L’Otellier, M., Jouen, F., Hau, F., Boumier, P., Tron, F., Gilbert, D., Fardellone, P., Cornélis, F., Le Loët, X., Vittecoq, O.

Get full text

Autoantibodies, metalloproteinases and bone markers in rheumatoid arthritis patients are unable to predict their responses to infliximab by Lequerré, T., Jouen, F., Brazier, M., Clayssens, S., Klemmer, N., Ménard, J.-F., Mejjad, O., Daragon, A., Tron, F., Le Loët, X., Vittecoq, O.

Get full text

Autoantibodies recognizing citrullinated rat filaggrin in an ELISA using citrullinated and non‐citrullinated recombinant proteins as antigens are highly diagnostic for rheumatoid a... by VITTECOQ, O., INÇAURGARAT, B., JOUEN‐BEADES, F., LEGOEDEC, J., LETOURNEUR, O., ROLLAND, D., GERVASI, G., MÉNARD, J. F., GAYET, A., FARDELLONE, P., DARAGON, A., JOLIVET, M., LE LOËT, X., TRON, F.

Get full text